» Articles » PMID: 2667939

Drug Treatment of Acute Leukaemia. Current Status

Overview
Journal Drugs
Specialty Pharmacology
Date 1989 Jun 1
PMID 2667939
Authors
Affiliations
Soon will be listed here.
Abstract

The drug treatment of acute leukaemia has changed considerably over the past years, offering the possibility of remission and, in some cases, cure. The broad outline of treatment schedules, the drugs in current use and newer approaches to therapy are discussed. Bone marrow transplantation is described in brief, as well as the role of support therapy.

References
1.
Gale R, Foon K . Acute myeloid leukaemia: recent advances in therapy. Clin Haematol. 1986; 15(3):781-810. View

2.
Clayton P, Shalet S, Price D . Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1988; 1(8583):460-2. DOI: 10.1016/s0140-6736(88)91246-9. View

3.
Thomas E, Buckner C, Clift R, Fefer A, Johnson F, Neiman P . Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med. 1979; 301(11):597-9. DOI: 10.1056/NEJM197909133011109. View

4.
Von Hoff D, Layard M, Basa P, Davis Jr H, Von Hoff A, Rozencweig M . Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979; 91(5):710-7. DOI: 10.7326/0003-4819-91-5-710. View

5.
Donohue S, Boughton B . Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults. Cancer Chemother Pharmacol. 1989; 23(6):401-2. DOI: 10.1007/BF00435846. View